These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38435072)

  • 1. A CKD Clinical Decision Support System: A Cluster Randomized Clinical Trial in Primary Care Clinics.
    Sperl-Hillen J; Crain AL; Wetmore JB; Chumba LN; O'Connor PJ
    Kidney Med; 2024 Mar; 6(3):100777. PubMed ID: 38435072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic clinic randomized trial to improve chronic kidney disease care: Design and adaptation due to COVID disruptions.
    Sperl-Hillen JM; Crain AL; Chumba L; Ekstrom HL; Appana D; Kopski KM; Wetmore JB; Wheeler J; Ishani A; O'Connor PJ
    Contemp Clin Trials; 2021 Oct; 109():106501. PubMed ID: 34271175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial.
    Harasemiw O; Drummond N; Singer A; Bello A; Komenda P; Rigatto C; Lerner J; Sparkes D; Ferguson TW; Tangri N
    Can J Kidney Health Dis; 2019; 6():2054358119841611. PubMed ID: 31191908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Kidney Failure Risk Prediction Clinical Decision Support on Monitoring and Referral in Primary Care Management of CKD: A Randomized Pragmatic Clinical Trial.
    Samal L; D'Amore JD; Gannon MP; Kilgallon JL; Charles JP; Mann DM; Siegel LC; Burdge K; Shaykevich S; Lipsitz S; Waikar SS; Bates DW; Wright A
    Kidney Med; 2022 Jul; 4(7):100493. PubMed ID: 35866010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial.
    Carroll JK; Pulver G; Dickinson LM; Pace WD; Vassalotti JA; Kimminau KS; Manning BK; Staton EW; Fox CH
    JAMA Netw Open; 2018 Oct; 1(6):e183377. PubMed ID: 30646261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Clinical Decision Support on Cardiovascular Risk Among Adults With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Cluster Randomized Clinical Trial.
    Rossom RC; Crain AL; O'Connor PJ; Waring SC; Hooker SA; Ohnsorg K; Taran A; Kopski KM; Sperl-Hillen JM
    JAMA Netw Open; 2022 Mar; 5(3):e220202. PubMed ID: 35254433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic Health Record Population Health Management for Chronic Kidney Disease Care: A Cluster Randomized Clinical Trial.
    Jhamb M; Weltman MR; Devaraj SM; Lavenburg LU; Han Z; Alghwiri AA; Fischer GS; Rollman BL; Nolin TD; Yabes JG
    JAMA Intern Med; 2024 Jul; 184(7):737-747. PubMed ID: 38619824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial.
    Peralta CA; Livaudais-Toman J; Stebbins M; Lo L; Robinson A; Pathak S; Scherzer R; Karliner LS
    Am J Kidney Dis; 2020 Nov; 76(5):636-644. PubMed ID: 32682696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Decision Support for Hypertension Management in Chronic Kidney Disease: A Randomized Clinical Trial.
    Samal L; Kilgallon JL; Lipsitz S; Baer HJ; McCoy A; Gannon M; Noonan S; Dunk R; Chen SW; Chay WI; Fay R; Garabedian PM; Wu E; Wien M; Blecker S; Salmasian H; Bonventre JV; McMahon GM; Bates DW; Waikar SS; Linder JA; Wright A; Dykes P
    JAMA Intern Med; 2024 May; 184(5):484-492. PubMed ID: 38466302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Care for Patients With or at Risk for Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster-Randomized Trial Protocol.
    Nash DM; Ivers NM; Young J; Jaakkimainen RL; Garg AX; Tu K
    Can J Kidney Health Dis; 2017; 4():2054358117699833. PubMed ID: 28607686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to Improve Blood Pressure Control Among Socioeconomically Disadvantaged Patients With CKD: Kidney Awareness Registry and Education Pilot Randomized Controlled Trial.
    Tuot DS; Rubinsky AD; Velasquez A; McCulloch CE; Schillinger D; Handley MA; Hsu CY; Powe NR
    Kidney Med; 2019; 1(5):242-252. PubMed ID: 32734204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pragmatic Cluster Randomized Trial of an Electronic Clinical Decision Support System to Improve Chronic Kidney Disease Management in Primary Care: Design, Rationale, and Implementation Experience.
    Khoong EC; Karliner L; Lo L; Stebbins M; Robinson A; Pathak S; Santoyo-Olsson J; Scherzer R; Peralta CA
    JMIR Res Protoc; 2019 Jun; 8(6):e14022. PubMed ID: 31199334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD).
    Fox CH; Vest BM; Kahn LS; Dickinson LM; Fang H; Pace W; Kimminau K; Vassalotti J; Loskutova N; Peterson K
    Implement Sci; 2013 Aug; 8():88. PubMed ID: 23927603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD).
    Litvin CB; Hyer JM; Ornstein SM
    J Am Board Fam Med; 2016; 29(5):604-12. PubMed ID: 27613793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic Randomized Trial.
    Tuot DS; McCulloch CE; Velasquez A; Schillinger D; Hsu CY; Handley M; Powe NR
    Am J Kidney Dis; 2018 Aug; 72(2):168-177. PubMed ID: 29699885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.
    Samal L; Wright A; Waikar SS; Linder JA
    BMC Nephrol; 2015 Oct; 16():162. PubMed ID: 26458541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.